Skip to main content
Pharming Group N.V. logo

Pharming Group N.V. — Investor Relations & Filings

Ticker · PHARM ISIN · NL0010391025 LEI · 724500DCJ9MPG74JEH91 AS Manufacturing
Open in API
Filings indexed 796 across all filing types
Latest filing 2024-05-02 Annual Report (ESEF)
Country NL Netherlands
Listing AS PHARM

About Pharming Group N.V.

https://www.pharming.com/

Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.

Recent filings

Filing Released Lang Actions
Annual Report (ESEF) 2023
Annual Report (ESEF) Classification · 1% confidence FY 2023
2024-05-02 English
6-K
Foreign Filer Report
2024-04-25 English
6-K
Foreign Filer Report
2024-04-24 English
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
Regulatory Filings Classification · 1% confidence The document is a press release from Pharming Group N.V. dated April 24, 2024, announcing that the company is receiving a 'Rare Impact Award' from the National Organization for Rare Disorders (NORD®) for the commercialization of its drug Joenja (leniolisib). This type of announcement, which communicates a specific, non-financial corporate event (an award recognition) and includes quotes from management and background information on the drug/disease, is characteristic of a general corporate announcement or press release. Since there is no specific category for 'Award Announcement' and it is not a formal regulatory filing like a 10-K, ER, or IR, it best fits the general regulatory/corporate announcement category, which is RNS (Regulatory Filings) as the fallback for miscellaneous announcements that don't fit elsewhere, or potentially a general Investor Relations communication, but RNS is the designated fallback for non-standard announcements.
2024-04-24 Dutch
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
Regulatory Filings Classification · 1% confidence The document is a press release dated April 24, 2024, announcing that Pharming Group N.V. will be honored by the National Organization for Rare Disorders (NORD) at the Rare Impact Awards. It details the reason for the award (commercialization of Joenja®) and includes quotes from NORD and Pharming executives. The text structure, use of 'press release,' and forward-looking statements section are characteristic of an official company announcement, but it is not a formal regulatory filing like a 10-K, IR, or ER. It is an announcement about an award/recognition, which does not fit neatly into the primary financial reporting categories (10-K, IR, ER, MRQ). Since it is a general corporate announcement that doesn't fit specific categories like MANG, DIV, or CAP, the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general announcement category for non-standard corporate news releases.
2024-04-24 English
Pharming Group to report first quarter 2024 financial results on May 8
Report Publication Announcement Classification · 1% confidence The document is a short announcement (2422 characters) stating that Pharming Group N.V. will publish its unaudited financial results for the first quarter of 2024 on May 8, 2024. It also provides registration links for the accompanying conference call/webcast. Because the document is an announcement about the future release of financial results and provides details for an associated call, rather than containing the full financial report itself, it fits the definition of a Report Publication Announcement (RPA). It is not the Earnings Release (ER) itself, which would contain the actual results highlights.
2024-04-24 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.